Preclinical Assessment of mesenchymal stromal cell (MSC) transplantation to treat type II (age-related) osteoporosis.

JOURNAL OF BONE AND MINERAL RESEARCH(2013)

Cited 0|Views3
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined